Dosage Forms

Reshaping Dosage Forms

Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Frontrunners in Bispecific Antibodies

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Topical Formulation: Moving From Art to Science

September 01, 2016

Analytics and science-based approaches are shedding more light on these complex dosage forms, promising to improve process control and product design.

Advances in the Regulated Pharmaceutical Use of Dimethyl Sulfoxide USP, Ph.Eur.

September 01, 2016

The authors review the regulatory changes associated with the use of dimethyl sulfoxide in finished pharmaceutical dosage forms.

Sartorius Stedim Biotech Introduces Fully Integrated Upstream Platform

September 01, 2016

The platform combines an expression system with equipment and process controls to enable rapid development and scale-up of robust titers.

Avantor Performance Materials, Nusil Technology to Merge

September 01, 2016

The merger of Avantor Performance Materials and Nusil Technology positions the company for growth in bioprocessing.

Industry Groups Applaud GDUFA Agreement

September 01, 2016

GPhA and PBOA commend agreement to reauthorize Generic Drug User Fee Amendments.

Parenteral Advisory: Outmoded Fill/Finish Technology

September 01, 2016

Improvements to aseptic manufacturing procedures are long overdue. But how feasible is it for manufacturers to modernize fill lines of legacy products?

Competition and Drug Pricing

August 30, 2016

Can Competition Block Excessive Pharma Price Hikes? EpiPen Saga Shows It’s Hard

PDA Issues Call to Action for Faster Postapproval Changes

August 29, 2016

The Parenteral Drug Association develops program to address barriers to implementation of postapproval changes.

Recipharm Expands Lyophilization Capacity in Italy

August 25, 2016

PTSM: Pharmaceutical Technology Sourcing and Management

Recipharm is investing EUR3.7 million (approximately $4.18 million) to increase lyophilization capacity at its Masate facility in Italy.

Alcami Expands US API Capacity

August 18, 2016

PTSM: Pharmaceutical Technology Sourcing and Management

CDMO Alcami adds HPAPI capacity and cryogenic capabilities to its Wisconsin facility.